Firm represents CMI and Warburg Pincus in sale of CMI to Roche Diagnostics.
On July 2, it was announced that Roche Diagnostics has acquired Constitution Medical Investors, Inc. Boston-based CMI, the developer of a highly innovative hematology testing system, was created and funded by private equity firm Warburg Pincus and members of CMI’s management team. Willkie advised CMI and Warburg Pincus in the transaction. CMI’s hematology testing system is designed to provide faster and more accurate diagnosis of blood-related diseases. Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. It is the world’s largest biotech company and the world leader for in vitro diagnostics and tissue-based cancer diagnostics.
The deal was handled by a multidisciplinary Willkie team including: Corporate – partners Steven Gartner and Robert Langdon, special counsel Jonathan Konoff and associates Michael Brandt, Laura Acker and Hania Masud; Benefits – partner Michael Katz and associate Rose Ohanesian; Tax – partner Hillel Jacobson and associate Matthew Movafaghi; Intellectual Property – partner Eugene Chang, special counsel Kim Walker and associate Amir Ghavi; Real Estate – special counsel Daniel Backer and associate Kathryn Allen; Environmental – of counsel William Thomas and associate Barbara Block and Antitrust – partner Wesley Powell and associate David Stoltzfus.